Version 4.0.201701

Home - Cell Index - Search - Web Sites
Species - Tissues - Tumors - Pathologies - Tr. Agents
Collections - Laboratories - Catalogues

For information, get in touch with: Dott.ssa Paola Visconti
Email: paola.visconti@hsanmartino.it
   P. Romano, A. Manniello et al. Nucl Acids Res 2009 37:D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105

Short description of cell lines
Species: human (all ethnic groups)


- By clicking on the cell line name, you will retrieve the detailed description of the cell line
- By clicking on one of the terms between parentheses, you will retrieve the list of all relevant cell line

1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

H 9 (leukemia, acute lymphoblastic) - IZSBS
H-A88 (amnion, trisomy 21 / Down syndrome) - GGB
H-EMC-SS (muscle, chondrosarcoma) - ECACC
H-EMC-SS (chondrosarcoma) - ICLC
H33HJ-JA1 (blood, lymphoma) - ECACC
H4 (brain, nervous tissue glial tumor) - IZSBS
H454 (cervix, carcinoma, epitheloid) - NAUBC
H460 (lung, adenocarcinoma) - MIISB
H69 (lung, carcinoma, small cell) - ECACC
H69V (lung, carcinoma, small cell) - ECACC
H9 (blood, lymphoma) - ECACC
H9 (lymphocyte, T, lymphoma) - ICLC
HBL-100 (breast, cancer) - SPBIC
HCT 116 (colon, carcinoma) - ECACC
HCT 116 (colon, carcinoma) - IZSBS
HCT-116 (colon, carcinoma) - ICLC
HCT-15 (colon, adenocarcinoma) - ECACC
HCT-15 (colon, colorectal adenocarcinoma) - ICLC
HCT-8 (intestine, ileocecal, adenocarcinoma) - ECACC
HCT-8 (intestine, ileocecal, adenocarcinoma) - GEIOM
HCT-8 (intestine, ileocecal, adenocarcinoma) - ICLC
HCT-8 (intestine, ileocecal, adenocarcinoma) - IZSBS
HDLM-2 (lymphoma, Hodgkin) - DSMZ
HEC-1-B (endometrium, adenocarcinoma) - BSUPG
HECV (umbilical cord) - ICLC
HEL (peripheral blood, erythroleukemia) - DSMZ
HEL (skin, fibroblast) - GEIMM
HEL 12469 (lung, embryonic) - ECACC
HEL 299 (lung, embryonic) - BGEBS
HEL 299 (lung, embryonic) - ECACC
HEL 299 (lung, embryonic) - IZSBS
HEL 299 (lung, embryonic) - PNIOS
HEL 92.1.7 (blood, erythroleukemia) - ECACC
HEL 92.1.7 (erythroleukemia) - ICLC
HeLa (cervix, carcinoma, epitheloid) - BGEBS
HeLA (cervix, carcinoma, epitheloid) - DSMZ
HeLa (cervix, carcinoma, epitheloid) - ECACC
HeLa (cervix, carcinoma, epitheloid) - ICLC
HeLa (cervix, carcinoma, epitheloid) - IZSBS
HeLa (cervix, carcinoma, epitheloid) - MIEOS
HeLa (cervix, carcinoma, epitheloid) - MWIIW
HeLa (cervix, carcinoma, epitheloid) - RMEBA
HeLa 229 (cervix, carcinoma, epitheloid) - IZSBS
HeLa 229 (cervix, carcinoma, epitheloid) - PRUMB
HeLa 382 (cervix, carcinoma) - GEIBM
HeLa 382 (cervix, carcinoma, epitheloid) - ICLC
HeLa 422 (cervix, carcinoma) - GEIBM
HeLa 422 (cervix, carcinoma, epitheloid) - ICLC
HeLa 432 (cervix, carcinoma) - GEIBM
HeLa 432 (cervix, carcinoma, epitheloid) - ICLC
HeLa B (cervix, carcinoma) - ECACC
HeLa LChm (cervix, carcinoma) - MWIIW
HeLa M (cervix, carcinoma) - SPBIC
HeLa Ohio (cervix, carcinoma, epitheloid) - ECACC
HeLa S 3 (cervix, carcinoma, epitheloid) - IZSBS
HeLa S3 (cervix, carcinoma, epitheloid) - ECACC
HeLa S3 (cervix, carcinoma, epitheloid) - ICLC
HeLa S3 (cervix, carcinoma, epitheloid) - PVCIM
HeLa S3 (cervix, carcinoma, epitheloid) - SPBIC
HeLa TK- (cervix, carcinoma) - SPBIC
HELA-S3 (cervix, carcinoma) - DSMZ
HeLa229 (cervix, carcinoma, epitheloid) - ECACC
Hep 2 (larynx, carcinoma, epidermoid) - IZSBS
Hep 3B (liver, carcinoma, hepatocellular) - ECACC
Hep 3B (liver, carcinoma, hepatocellular) - MIISB
Hep 3B2.1-7 (liver, carcinoma, hepatocellular) - IZSBS
Hep G2 (liver, carcinoma, hepatocellular) - ECACC
Hep G2 (liver, carcinoma, hepatocellular) - GEUCC
Hep G2 (liver, carcinoma, hepatocellular) - ICLC
Hep G2 (liver, carcinoma, hepatocellular) - IZSBS
Hep G2 (liver, carcinoma, hepatocellular) - MIECC
Hep G2 (liver, carcinoma, hepatocellular) - MIUFC
Hep G2 (liver, carcinoma, hepatocellular) - PGUPG
Hep G2 (liver, carcinoma, hepatocellular) - SPBIC
Hep G2 (liver, carcinoma, hepatocellular) - TOHEP
HEp-2 (larynx, carcinoma, squamous cell) - MWIIW
HEp-2 (larynx, carcinoma, squamous cell) - PRUMB
Hep-2 (larynx, carcinoma, squamous cell) - RMSTC
HEp-2 (larynx, carcinoma, squamous cell) - SIUVI
HEp-2 (larynx, carcinoma, squamous cell) - SPBIC
Hep-2C (larynx, carcinoma) - ECACC
HEP-3B (liver, carcinoma, hepatocellular) - DSMZ
HEP-G2 (liver, carcinoma, hepatocellular) - DSMZ
Hep2 (larynx, carcinoma) - ECACC
Hep2 (Clone 2B) (larynx, carcinoma) - ECACC
HEPM (palatal mesenchyme, embryonic) - ECACC
HF 19 (lung, embryonic) - RMSTC
HF19 (lung, embryonic) - ECACC
HFFF2 (foreskin, fetal) - ECACC
HFFF2 (foreskin, fetal) - ICLC
HFL (lung) - IZSBS
HFL1 (lung, embryonic) - ECACC
HG 261 (skin, fibroblast, Fanconi anemia) - IZSBS
HG261 (skin, fibroblast, Fanconi anemia) - ECACC
HGC-27 (lymph node, carcinoma) - ECACC
HGC-27 (stomach, carcinoma, undifferentiated) - ICLC
HGF (gingival stroma) - RMUPG
HGF 24 (gingival stroma) - IZSBS
HK 0-32 (skin, keratinocyte) - MIUCO
HK 0-42 (skin, keratinocyte) - MIUCO
HK 0-43 (skin, keratinocyte) - MIUCO
HK 0-44 (skin, keratinocyte) - MIUCO
HK 0-45 (skin, keratinocyte) - MIUCO
HL 60 (peripheral blood, leukemia) - IZSBS
HL-60 (peripheral blood, leukemia, promyelocytic) - ANIIR
HL-60 (peripheral blood, leukemia, promyelocytic) - BOHIC
HL-60 (peripheral blood, leukemia, acute myeloid) - DSMZ
HL-60 (peripheral blood, leukemia, promyelocytic) - ICLC
HL-60 (peripheral blood, leukemia, promyelocytic) - MIISB
HL-60 (peripheral blood, leukemia, promyelocytic) - PNIOS
HL-60 (peripheral blood, leukemia, promyelocytic) - RMUFM
HL-60 (peripheral blood, leukemia, promyelocytic) - SPBIC
HL60 (peripheral blood, leukemia, promyelocytic) - ECACC
HL60 15-12 (peripheral blood, leukemia, promyelocytic) - ECACC
HL60 Ast.3 (peripheral blood, leukemia, promyelocytic) - ECACC
HL60 Ast.4 (peripheral blood, leukemia, promyelocytic) - ECACC
HL60 M2 (peripheral blood, leukemia, promyelocytic) - ECACC
HL60 M4 (blood, leukemia, promyelocytic) - ECACC
HLF-a (lung, carcinoma, epidermoid) - ECACC
HMVII (vagina, melanoma) - ECACC
HN (kidney, hypernephroma) - SPBIC
HOS (bone, osteosarcoma) - ECACC
HOS (bone, osteosarcoma) - ICLC
HOS (bone, osteosarcoma) - IZSBS
HOS (TE85, Clone F5) (bone, osteosarcoma) - MIISA
HOS (TE85, Clone F5) (bone, osteosarcoma) - MWIIW
HOS (TE85, Clone F5) (bone, osteosarcoma) - SPBIC
HR5 (cervix, carcinoma) - ECACC
HR5-CL11 (cervix, carcinoma) - ECACC
HRT 18 (rectum-anus, adenocarcinoma) - IZSBS
HRT-18 (rectum-anus, adenocarcinoma) - ECACC
Hs 27 (foreskin) - ECACC
Hs 431 (connective, carcinoma) - ECACC
Hs 578Bst (breast) - MIEOS
Hs 578T (breast, carcinoma, ductal) - ECACC
Hs 578T (breast, carcinoma) - ICLC
Hs 578T (breast, carcinoma, ductal) - SPBIC
Hs 633T (fibrosarcoma) - ECACC
Hs 68 (foreskin) - ECACC
Hs 683 (neuroglia, glioma) - IZSBS
Hs 863.T (bone, sarcoma, Ewing's) - IZSBS
HS 883.T (bone, giant cell, sarcoma) - IZSBS
HS 888 Lu (lung) - IZSBS
Hs 888Lu (lung) - ECACC
Hs-27 (foreskin) - IZSBS
HS-Sultan (blood, plasmacytoma) - ECACC
Hs913T (fibrosarcoma) - ICLC
HSF (skin, fibroblast) - MIECC
HSFPD (skin, fibroblast, Parkinson disease) - MIECC
HT 1080 (acetabulum, fibrosarcoma) - ECACC
HT 1080 (acetabulum, fibrosarcoma) - IZSBS
HT 1197 (bladder, carcinoma) - ECACC
HT 1197 (bladder, carcinoma) - ICLC
HT 1376 (bladder, carcinoma) - ECACC
HT 1376 (bladder, carcinoma) - IZSBS
HT-1080 (acetabulum, fibrosarcoma) - BGEBS
HT-1080 (acetabulum, fibrosarcoma) - CHIBC
HT-1080 (acetabulum, fibrosarcoma) - GEICH
HT-1080 (acetabulum, fibrosarcoma) - ICLC
HT-1080 (acetabulum, fibrosarcoma) - MIEOS
HT-1080 (acetabulum, fibrosarcoma) - SPBIC
HT-29 (colon, adenocarcinoma, grade II) - ICLC
HT-29 (colon, adenocarcinoma) - IZSBS
HT-29 (colon, adenocarcinoma, grade II) - MIEOS
HT-29 (colon, adenocarcinoma, grade II) - MIILC
HT-29 (colon, adenocarcinoma, grade II) - MIISB
HT-29 (colon, adenocarcinoma, grade II) - MWIIW
HT-29 (colon, adenocarcinoma, grade II) - RMICS
HT-29 (colon, adenocarcinoma, grade II) - TOUCI
HT115 (colon, carcinoma) - ECACC
HT29 (colon, adenocarcinoma, grade II) - ECACC
HT29 gluc C1 (colon, adenocarcinoma) - ECACC
HT29/219 (colon, adenocarcinoma) - ECACC
HT55 (colon, carcinoma) - ECACC
HTK- (bone, osteomyeloma) - ECACC
HtTA-1 (cervix, carcinoma) - ECACC
HUC-Fm (umbilical cord) - ECACC
HUP-T3 (pancreas, carcinoma) - DSMZ
HuP-T3 (pancreas, adenocarcinoma) - ECACC
HuP-T3 (pancreas, adenocarcinoma) - ICLC
HUP-T4 (pancreas, carcinoma) - DSMZ
HuP-T4 (pancreas, adenocarcinoma) - ECACC
HuP-T4 (pancreas, adenocarcinoma) - ICLC
HuT 102 (lymphoma, cutaneous, T cell) - GEIIB
HuT 78 (peripheral blood, lymphoma, cutaneous, T cell) - RMSVI
HUT-78 (peripheral blood, lymphoma, cutaneous, T cell) - ECACC
HuTu 80 (adenocarcinoma) - IZSBS
HuTu 80 (duodenum, adenocarcinoma) - SPBIC
HUVEC (endothelium) - ICLC

For information, get in touch with:
IRCCS Ospedale Policlinico San Martino
Largo Rosanna Benzi, 10 - I-16132 Genova - Italy
Dott.ssa Paola Visconti
Email: paola.visconti@hsanmartino.it

If you want to cite CLDB and HyperCLDB, please use the following reference:

P. Romano, A. Manniello, O. Aresu, M. Armento, M. Cesaro, B. Parodi.
Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines.
Nucleic Acids Research 2009 37(Database issue):D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105